The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.

GSK PLC GSK shares rose 1.78% to £13.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% to 9,061.49. GSK PLC ...

As of June 30, the Fund held 46.2% in U.S. equities, 17.9% in non-U.S. equities, and 35.9% in fixed income securities plus ...

After strong multi-year performance in Financials, Dodge & Cox Global Stock Fund continued to steadily reduce its overweight position in the sector. Read more here.

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

The FDA oncologic drugs advisory committee voted against the approval of GSK’s blood cancer treatment Blenrep, delivering a setback to the drugmaker’s efforts to reintroduce the drug to the U.S.

London's main stock indexes rose on Friday, with the blue-chip index hovering near record highs, aided by a slew of positive ...

The FTSE 100 index of leading shares has broken through 9,000 for the first time. That’s not as impressive as it ...